Early Detection
Early Detection-ELSA Seq Methylation Based Multi-Cancer Early Detection Assay
![](https://us.brbiotech.com/wp-content/uploads/2021/02/2-1.png)
Lung, colorectal, liver, ovarian, pancreatic, esophageal, gastric, cholangio, head and neck
![](https://us.brbiotech.com/wp-content/uploads/2021/02/1-2.png)
3 -> 6 -> 9 cancer
![](https://us.brbiotech.com/wp-content/uploads/2021/02/3-1.png)
~80% sensitivity @ 98% specificity
![](https://us.brbiotech.com/wp-content/uploads/2021/02/6.png)
Performance comparable to Grail’s assay (outperformed on lung and colorectal)
![](https://us.brbiotech.com/wp-content/uploads/2021/02/5.png)
Can be used to supplement at risk screening (For example: colonoscopy)
![](https://us.brbiotech.com/wp-content/uploads/2021/02/4.png)
Improve early detection and improve patient outcomes
![disease-img3](https://us.brbiotech.com/wp-content/uploads/2021/01/disease-img3.jpg)
![disease-img1](https://us.brbiotech.com/wp-content/uploads/2021/01/disease-img1-1.jpg)